Pathogenesis and treatment of NIDDM and its related problems : proceedings of the Fourth International Symposium on Treatment of Diabetes Melliuts, Nagoya, 26-23 October 1993
著者
書誌事項
Pathogenesis and treatment of NIDDM and its related problems : proceedings of the Fourth International Symposium on Treatment of Diabetes Melliuts, Nagoya, 26-23 October 1993
(International congress series, no. 1057)
Excerpta Medica, 1994
- : alk. paper
大学図書館所蔵 全7件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes indexes
内容説明・目次
内容説明
This publication is a presentation of the papers from the Fourth International Symposium on Treatment of Diabetes Mellitus. It charts progress in the area of scientific research on NIDDM (non-insulin-dependent diabetes mellitus) and its related complications.
目次
- Part 1 Plenary lectures: pathogenesis of complications in NIDDM, N. Sakamoto
- drug therapy in NIDDM - update, T. Kaneko. Part 2 Luncheon lectures: model care of NIDDM in 1993, J.R. Turtle et al
- animal models of NIDDM - what did GK rats teach us?, T. Toyota. Part 3 Frontiers of diabetes research: current concepts of the role of polyol metabolism and related metabolic abnormalities in diabetic complications, J.R. Williamson et al
- the glucose transporter family, D.E. James. Part 4 New insights of diabetes treatment and care: treatment of hyperlipidemia and atherosclerosis in NIDDM, Y. Akanuma
- the relevance of the St. Vincent declaration to world wide NIDDM care, J. Jervell. Part 5 Etiology and pathogenesis of NIDDM: clinical and genetic analysis of mitochondrial DNA mutation in patients with diabetes mellitus, Y. Nakagawa et al
- new efficient assay for aldose reductase activity, Y. Hamada et al
- sleep disordered breathing and impaired glucose tolerance of aged patients with cerebrovascular diseases, K. Katsumata et al
- fat distribution in NIDDM - comparison between insulin and sulfonylurea treatment, A. Yamauchi et al. Part 6 Insulin action and its related-regulatory mechanisms: different processing of abnormal insulin receptors with mutations at the extracellular domain and the intracellular domain, M. Kobayashi et al
- insulin therapy in NIDDM - attempt to restore insulin secretion and to augment hepatic glucose uptake, R. Kawamori et al
- insulin resistance rather than hyperinsulinemia contributory to essential hypertension, C. Yokota et al
- completely noninvasive measurements of human blood glucose in vivo using near infrared waves, M. Noda et al. Part 7 New aspects of treatment in NIDDM: national implementation of a structured treatment and teaching programme (TTP) for NIDDM in Germany, I. Mulhauser et al
- beneficial effects of biguanides on diabetic patients with and without insulin treatment, S. Kawazu et al
- comparison between effects of glimepiride and glibenclamide on in vivo insulin action, J. Sato et al
- clinical applications of the wearable artificial endocrine pancreas with the newly designed needle-type glucose sensor, K. Nishida et al. Part 8 Risk factors of atherosclerosis in NIDDM: study on standard treatment lipid levels in diabetics, C. Ito et al
- plasminogen activator inhibitor-1 and fasting plasma insulin levels in NIDDM, F. Nakaya et al. Part 9 NIDDM and diabetic complications: effects of epalrestat on early diabetic nephropathy in clinical and experimental studies, S. Isogai et al
- observation of the intimal thickening of diabetic rats after denudation of the endothelium, S. Nakamoto et al
- changes in diabetic retinopathy in patients undergoing rapid glycemic control during pregnancy, M. Shimizu et al
- pancreatic cancer screened by ultrasonography in diabetics, Y. Atsumi et al. (Part Contents).
「Nielsen BookData」 より